| Janssen-Cilag AG - Rybrevant SC 3520 mg/22 ml, Injektionslösung | | 69839 | | 04 | | Rybrevant SC 3520 mg/22 ml | | Injektionslösung | | L01FX18 | | Amivantamab | | 30.09.2026 | | |
| | Composition | | amivantamabum 3520 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80 13.2 mg, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 22 ml corresp. natrium 13.6 mg. | | Packungsbestandteile | | Injection solution | | | | | | Active Agent | Dose |
|---|
| Amivantamabum | 3520mg / 22ml |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Dinatrii Edetas | | | Hyaluronidasum Humanum Adnr | | | Methionine | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | 13.2mg / 22ml | | Saccharum | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | | | | A | | No |
|
|
